Jie Zan Selected Research

Jie Zan Research Topics

Disease

7	Brain Ischemia (Cerebral Ischemia) 09/2023 - 11/2017
6	Infections 04/2017 - 07/2013
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2023 - 11/2017
3	Neoplasms (Cancer) 02/2024 - 10/2016
3	Atherosclerosis 12/2022 - 08/2015
3	Virus Diseases (Viral Diseases) 01/2022 - 01/2017
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2024 - 01/2018
2	Brain Injuries (Brain Injury) 09/2023 - 01/2023
2	Ischemic Stroke 01/2023 - 01/2022
2	Inflammation (Inflammations) 01/2023 - 12/2022
2	Neuroblastoma 06/2020 - 01/2019
2	Ischemia 06/2020 - 11/2017
1	Adenocarcinoma of Lung 02/2024
1	Chronic Renal Insufficiency 01/2024
1	Lung Injury 12/2023
1	Acute Lung Injury 12/2023
1	Sepsis (Septicemia) 12/2023
1	Alzheimer Disease (Alzheimer's Disease) 10/2023
1	Melanoma (Melanoma, Malignant) 09/2023
1	Parkinson Disease (Parkinson's Disease) 01/2023
1	Bites and Stings (Sting) 01/2023
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2023
1	Latent Infection 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	RNA Virus Infections 11/2020
1	Reperfusion Injury 11/2020
1	Hypoxia (Hypoxemia) 01/2019
1	Stroke (Strokes) 01/2018
1	Lymphoma (Lymphomas) 11/2017
1	Infarction (Infarctions) 11/2017
1	Carcinogenesis 10/2016
1	Atherosclerotic Plaque (Atheroma) 10/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016
1	Rabies (Hydrophobia) 01/2016

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2013
5	Messenger RNA (mRNA)IBA 01/2023 - 11/2017
4	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2023
3	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 11/2020
3	Oxygen (Dioxygen)IBA 09/2023 - 11/2020
3	6-methyladenineIBA 01/2023 - 11/2020
3	Antiviral Agents (Antivirals)IBA 11/2020 - 10/2016
3	isosteviolIBA 01/2019 - 11/2017
3	SodiumIBA 01/2019 - 11/2017
2	tangeretinIBA 12/2023 - 09/2023
2	InflammasomesIBA 12/2023 - 09/2023
2	oxidized low density lipoproteinIBA 12/2022 - 10/2016
2	MicroRNAs (MicroRNA)IBA 01/2022 - 06/2020
2	Interferon-betaIBA 01/2022 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2020
2	Neuroprotective AgentsIBA 06/2020 - 11/2017
2	Mitogen-Activated Protein KinasesIBA 01/2019 - 04/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 11/2017
2	Therapeutic UsesIBA 01/2018 - 11/2017
1	Gemcitabine FDA Link 02/2024
1	Glial Fibrillary Acidic ProteinIBA 01/2024
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2024
1	BI 6727IBA 12/2023
1	Polo-Like Kinase 1IBA 12/2023
1	UbiquitinIBA 10/2023
1	N-methyladenosineIBA 01/2023
1	Small Interfering RNA (siRNA)IBA 01/2023
1	CycloleucineIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Interferon Type IIBA 01/2022
1	InterferonsIBA 01/2022
1	LuciferasesIBA 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022
1	LipidsIBA 01/2021
1	SARS-CoV-2 spike proteinIBA 01/2021
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 11/2020
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 11/2020
1	Serine (L-Serine)FDA Link 11/2020
1	Threonine (L-Threonine)FDA Link 11/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2019
1	SaltsIBA 01/2019
1	CCAAT-Enhancer-Binding Protein-betaIBA 01/2019
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2019
1	NF-kappaB-Inducing KinaseIBA 11/2017
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 11/2017
1	Interleukin-1beta (Interleukin 1 beta)IBA 11/2017
1	Caspase 3 (Caspase-3)IBA 11/2017
1	AMP-Activated Protein KinasesIBA 04/2017
1	Sirolimus (Rapamycin)FDA Link 04/2017
1	Caspase 2IBA 04/2017
1	Viral RNAIBA 01/2017
1	Histone Deacetylase 6IBA 01/2017
1	TubulinIBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2016
1	Actin Depolymerizing Factors (Cofilins)IBA 01/2016
1	ChaperoninsIBA 07/2013

Therapy/Procedure

1	Intraperitoneal Injections 01/2023
1	Injections 01/2019
1	Sutures (Suture) 11/2017